Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $86.81 USD
Change Today +0.17 / 0.20%
Volume 111.2K
VAR On Other Exchanges
Symbol
Exchange
Frankfurt
As of 11:30 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

varian medical systems inc (VAR) Snapshot

Open
$86.79
Previous Close
$86.64
Day High
$87.10
Day Low
$86.15
52 Week High
04/23/15 - $96.67
52 Week Low
10/15/14 - $76.73
Market Cap
8.7B
Average Volume 10 Days
965.5K
EPS TTM
$4.13
Shares Outstanding
100.1M
EX-Date
01/5/99
P/E TM
21.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for VARIAN MEDICAL SYSTEMS INC (VAR)

varian medical systems inc (VAR) Related Businessweek News

View More BusinessWeek News

varian medical systems inc (VAR) Details

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions in the United States. The company operates in two segments, Oncology Systems and Imaging Components. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, and image processing software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians’ offices, and cancer care clinics. The Imaging Components segment provides X-ray imaging components to large imaging system original equipment manufacturers (OEMs) for use in radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, and industrial applications; and X-ray tubes and flat panel digital image detectors to small OEMs, independent service companies, and end-users for filmless X-ray imaging. This segment also offers Linatron X-ray accelerators, imaging processing software, and image detection products for security and inspection purposes, such as cargo screening at ports and borders, and nondestructive examination in various applications. Varian Medical Systems, Inc. also provides products and systems for delivering proton therapy; and develops various technologies in the areas of digital X-ray imaging, volumetric and functional imaging, and improved X-ray sources. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.

6,800 Employees
Last Reported Date: 04/29/15
Founded in 1948

varian medical systems inc (VAR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $934.6K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $587.0K
Executive Vice President and President of Onc...
Total Annual Compensation: $567.0K
Senior Vice President and President of Imagin...
Total Annual Compensation: $513.8K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $429.9K
Compensation as of Fiscal Year 2014.

varian medical systems inc (VAR) Key Developments

Varian Medical Systems, Inc. and Câncer de Barretos Enter into Long-Term Agreement Encompassing the Deployment of Advanced Technology

Varian Medical Systems and Hospital de Câncer de Barretos (HCB) in Brazil announced that they have entered into a long-term agreement encompassing the deployment of advanced technology for treating cancer as well as the establishment of a clinical training program at the hospital. HCB will acquire four new radiotherapy treatment systems representing the full spectrum of Varian's technology offerings. A TrueBeam®, Trilogy®, Clinac®, and UNIQUE™ radiotherapy system will be installed over a two year period. The hospital will also upgrade its suite of Varian software, including Eclipse™ and BrachyVision™ for treatment planning and ARIA® for managing oncology information. Varian will also work with the HCB clinical team to establish a clinical school at the hospital, to train clinicians from across Brazil and other countries in Latin America on the use of Varian technology to deliver advanced radiotherapy. The clinical school will be outfitted with a VERT™ virtual simulation and training system that enables doctors, physicists, dosimetrists, and radiation therapists to learn and practice planning and delivering a full range of treatment techniques.

Varian Medical Systems and Sarah Cannon Cancer Network Expand Integrated Technology for Radiation Oncology Program

Varian Medical Systems and Sarah Cannon announced a new initiative to upgrade the radiation oncology equipment across the Sarah Cannon Cancer Network of Excellence with newly advanced technology for image-guided, high-precision radiotherapy and radiosurgery. Sarah Cannon will also deploy Varian's new InSightive™ software for data analytics and RapidPlan™ knowledge-based treatment planning software together with Varian's ARIA® information management and Eclipse™ treatment planning software. The software will support Sarah Cannon's programs for using data to develop personalized treatment plans, improve outcomes, and expand clinical trial options for patients. The project is part of a long-term plan for enhancing and expanding radiotherapy and radiosurgery cancer treatment capabilities across the Sarah Cannon Cancer Network of Excellence. Sarah Cannon has access to more than 100,000 newly-diagnosed cancer patients per year and offers integrated cancer services with convenient access to cutting-edge therapies through its network of cancer programs across the United States and United Kingdom.

Varian Medical Systems, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended April 3, 2015; Provides Earnings Guidance for the Third Quarter and Full Year of 2015

Varian Medical Systems, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended April 3, 2015. For the quarter, the company reported revenues of $759.4 million compared to $778.5 million a year ago. Operating earnings were $146 million compared to $127.5 million a year ago. Earnings before taxes were $147.1 million compared to $128.1 million a year ago. Net earnings were $106 million or $1.05 per diluted share compared to $92.7 million or $0.88 per diluted share a year ago. Cash flow from operations for the second quarter was $53 million. For the six months, the company reported revenues of $1,497.3 million compared to $1,490.0 million a year ago. Operating earnings were $275.5 million compared to $269.5 million a year ago. Earnings before taxes were $277.5 million compared to $270.5 million a year ago. Net earnings were $199.3 million or $1.97 per diluted share compared to $190.7 million or $1.79 per diluted share a year ago. The company believe that for fiscal year 2015 total company earnings will be in the range of $4.02 to $4.14 per diluted share and that revenues will increase by about 1 to 2% in dollars and by about 5% in constant currency. The company now expect that challenges in Imaging Components business, as well as currency headwinds, will more than offset the earnings momentum of the first half. The company estimate that Imaging Components could negatively impact earnings by $0.08 to $0.12 per diluted share. Additionally, since guidance last quarter, the strength of the dollar has diminished earnings expectations by another $0.06 to $0.10 per diluted share. For the third quarter of fiscal 2015, the company believe total company revenues should be about equal to the prior-year period in dollars and up about 4% in constant currency. Net earnings per diluted share for the third quarter could be in the range of $0.90 to $0.94 per diluted share. The outlook for the third quarter and full fiscal year 2015 excludes any impact of proton orders not yet booked into backlog.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VAR:US $86.81 USD +0.17

VAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $51.34 USD -0.79
MEDNAX Inc $70.70 USD -0.52
Mettler-Toledo International Inc $321.40 USD +0.17
ResMed Inc $64.85 USD +0.24
Cooper Cos Inc/The $178.33 USD +0.89
View Industry Companies
 

Industry Analysis

VAR

Industry Average

Valuation VAR Industry Range
Price/Earnings 22.0x
Price/Sales 2.9x
Price/Book 5.3x
Price/Cash Flow 21.5x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VARIAN MEDICAL SYSTEMS INC, please visit www.varian.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.